Primary Record
Vincristine sulfate
- In stock
- 4,918 g
- Purity
- 99.3 %
- CAS
- 2068-78-2
Compound Identifiers & Properties
- CAS
- 2068-78-2
- PubChem CID
- 5388992
- SMILES
- CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
- Canonical SMILES
- CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
Names & Synonyms
- Vincristine sulfate
- Oncovin
- Vincrex
- Kyocristine
- Vincrisul
- vincristine
- Leurocristine
- Marqibo
- Onkovin
- Vincasar PFS
- Vincristinsulfat
- Vincristine sulphate
- Marqibo Kit
- Novopharm
- VCR sulfate
- vincristinesulfate
- Vincristine sulfate salt
- Vincristine (sulfate)
- Vincristine Sulfate PFS
- Vincristine Sulfate RS
- Vincristinsulfat [German]
- Lilly 37231
- Vincristine sulfate CRS
- Opera_ID_836
- UNII-T5IRO3534A
- 2068-78-2
- MLS000863277
- Vincristine sulfate (assay)
- C46H58N4O14S
- CCRIS 2583
- T5IRO3534A
- MLS000069706
- MLS001148250
- MLS001401434
- CHEMBL385978
- Leurocristine sulfate (1:1) (salt)
- SCHEMBL29519343
- VINCRISTINE SULFATE [MI]
- EINECS 218-190-0
- LILLY-37231
- Vincristine sulfate [USAN:JAN]
- VINCRISTINE SULFATE [JAN]
- AQTQHPDCURKLKT-PNYVAJAMSA-N
- NSC 67574
- NSC-67574
- Vincristine sulfate [USAN:USP:JAN]
- HMS2052D03
- HMS2234B06
- VINCRISTINE SULFATE [IARC]
- VINCRISTINE SULFATE [USAN]
- VINCRISTINE SULFATE [VANDF]
- DRG-0046
- HY-N0488
- Leurocristine, sulfate (1:1) (salt)
- VINCRISTINE SULFATE [MART.]
- Vincristine Sulfate Liposomes Injection
- C46H56N4O10.H2O4S
- Alkaloid extracted from Vinca rosea Linn
- MFCD00084729
- NA1544
- UN1544
- VINCRISTINE SULFATE [USP-RS]
- VINCRISTINE SULFATE [WHO-DD]
- VINCRISTINE SULFATE [WHO-IP]
- SMR000058540
- AKOS030497863
- AI3-52944
- CCG-101152
- CID5388992
- CS-1778
- EBC-152146
- NC00402
- VCR . sulfate;Leukocristine . sulfate
- Vincristine Sulfate (1mg/mL in DMSO)
- Vincristine Sulfate (1 mg/mL in DMSO)
- VINCRISTINE SULFATE [ORANGE BOOK]
- AS-12168
- CPD000058540
- SAM001246570
- Vincaleukoblastine, 22-oxo-, sulfate (1:1)
- VINCRISTINE SULFATE [EP MONOGRAPH]
- VINCRISTINI SULFAS [WHO-IP LATIN]
- Vincristine Sulfate (10 mg/mL in DMSO)
- VINCRISTINE SULFATE [USP MONOGRAPH]
- Vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt)
- C46-H56-N4-O10.H2-O4-S
- Vincaleucoblastina, 22-oxo-, sulfato (1:1)
- Q27095645
- Vincristine sulfate, meets USP testing specifications
- Vincristine sulfate salt, 95.0-105.0% (HPLC), powder
- 22-OXOVINCALEUKOBLASTINE SULFATE (1:1) (SALT) [WHO-IP]
- Vincristine sulfate, European Pharmacopoeia (EP) Reference Standard
- Vincristine sulfate, United States Pharmacopeia (USP) Reference Standard
- (3aR,3a1R,4R,5S,5aR,10bR)-methyl 4-acetoxy-3a-ethyl-9-((3R,5S,7S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hyd
- methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid
- methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate
- roxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate
- Vincristine sulfate; Methyl (3aR,4R,5S,5aR,10bR,13aR)-4-(acetyloxy)-3a-ethyl-9-[(5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-6-formyl-5-hydroxy-8-methoxy-3a,4,5,5a,6,11,12,13a-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate